Latest News and Press Releases
Want to stay updated on the latest news?
-
We have renewed our investigation into the fairness of the proposed sale of Silk Road Medical to Boston Scientific for $27.50 per share.
-
We are investigating the fairness of the proposed sale of Silk Road Medical to Boston Scientific for $27.50 per share in cash
-
We are investigating the fairness of the $71.00 per share in cash pursuant to which Axonics, Inc. has agreed to be sold to Boston Scientific
-
Covina, March 16, 2023 (GLOBE NEWSWIRE) -- The Plastic Injection Molding for Medical Device Market accounted for US$ 82.7 million in 2020 and is estimated to be US$ 148.88 million by 2030 and is...
-
Los Angeles, USA, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Implantable Cardiac Monitors Market Expected To Rise By A CAGR Of 4.4% By 2025The steady growth of the Implantable Cardiac monitors (ICM) market...
-
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Boston...
-
SALT LAKE CITY, Oct. 05, 2020 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.SINTX.com) (NASDAQ: SINT), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and...
-
FRAMINGHAM, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
-
SANTA MONICA, Calif., Feb. 13, 2020 (GLOBE NEWSWIRE) -- BIOMEDevice, the Boston region’s premier medical technology event, today announced two esteemed keynote speakers that will headline the...
-
LOS ANGELES, June 24, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Boston Scientific...